Holen Sie sich die Stockscreener-App
6.17
17.30%
0.91
Schlusskurs vom Vortag:
$5.26
Offen:
$5.76
24-Stunden-Volumen:
3.60M
Relative Volume:
13.17
Marktkapitalisierung:
$12.30M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-58.52M
KGV:
-2.9522
EPS:
-2.09
Netto-Cashflow:
$-45.03M
1W Leistung:
+23.65%
1M Leistung:
+1,224%
6M Leistung:
+649.70%
1J Leistung:
+290.51%
1-Tages-Spanne:
$5.3101
$6.42
1-Wochen-Bereich:
$4.91
$6.42
52-Wochen-Spanne:
$0.224
$6.42
Nextcure Inc Stock (NXTC) Company Profile
Firmenname
Nextcure Inc
Sektor
Branche
Telefon
240-399-4900
Adresse
9000 VIRGINIA MANOR ROAD, SUITE 200, BELTSVILLE, MD
Vergleichen Sie NXTC mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
NXTC
Nextcure Inc
|
6.17 | 12.30M | 0 | -58.52M | -45.03M | -2.09 |
|
VRTX
Vertex Pharmaceuticals Inc
|
469.65 | 121.28B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.10 | 60.96B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
328.81 | 42.77B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
591.99 | 36.21B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
291.47 | 32.08B | 3.81B | -644.79M | -669.77M | -6.24 |
Nextcure Inc Stock (NXTC) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2022-11-04 | Herabstufung | Ladenburg Thalmann | Buy → Neutral |
| 2022-03-01 | Eingeleitet | Ladenburg Thalmann | Buy |
| 2021-03-05 | Hochstufung | Truist | Hold → Buy |
| 2021-01-15 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2020-07-16 | Hochstufung | The Benchmark Company | Hold → Buy |
| 2020-07-13 | Herabstufung | ROTH Capital | Buy → Neutral |
| 2020-07-13 | Herabstufung | SunTrust | Buy → Hold |
| 2020-06-01 | Herabstufung | BofA/Merrill | Buy → Neutral |
| 2020-06-01 | Herabstufung | The Benchmark Company | Buy → Hold |
| 2020-05-26 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2020-03-24 | Eingeleitet | The Benchmark Company | Buy |
| 2020-03-02 | Eingeleitet | ROTH Capital | Buy |
| 2020-01-13 | Eingeleitet | SunTrust | Buy |
| 2019-12-05 | Eingeleitet | Needham | Buy |
| 2019-11-26 | Eingeleitet | BTIG Research | Buy |
| 2019-07-09 | Eingeleitet | BofA/Merrill | Buy |
| 2019-06-03 | Eingeleitet | Morgan Stanley | Overweight |
| 2019-06-03 | Eingeleitet | Piper Jaffray | Overweight |
Alle ansehen
Nextcure Inc Aktie (NXTC) Neueste Nachrichten
Is NextCure Inc. a good long term investmentGame-changing returns - PrintWeekIndia
NXTC Stock: Exploring Nextcure Inc’s Growth - investchronicle.com
What drives NextCure Inc. stock priceConsistent double returns - PrintWeekIndia
NextCure stock soars after positive data for bone disease treatment - Investing.com India
NextCure Soars On Encouraging Preclinical Data Of Brittle Bone Disease Drug Candidate - Nasdaq
NextCure Inc. Stock Analysis and ForecastPhenomenal returns - Autocar Professional
Nextcure Stock Skyrockets Nearly 45% In After-Hours Trading After Sharing Preclinical Data For Brittle Bone Disease - 富途牛牛
What analysts say about NextCure Inc. stockSuperior return velocity - PrintWeekIndia
NextCure Stock Soars After-Hours On Promising Preclinical Data For Rare Bone Disease Treatment - MSN
How NextCure Inc. stock performs during market volatilityRisk Adjusted Stock Signals - Newser
NextCure, Inc. Presents Promising Preclinical Data for NC605 in Osteogenesis Imperfecta at Brittle Bone Society Meeting - Nasdaq
Preclinical Data Demonstrate Anti-Siglec-15 Treatment Improves Bone Microarchitecture and Reduces Fracture Incidence in Mice with Moderate-to-Severe Osteogenesis Imperfecta - The Manila Times
What makes NextCure Inc. stock price move sharplyConsistent Growth Alert - Newser
Why NextCure Inc. stock attracts strong analyst attentionFree Access to Community - Newser
Piper Sandler lowers NextCure stock price target to $15 after reverse split By Investing.com - Investing.com South Africa
Piper Sandler lowers NextCure stock price target to $15 after reverse split - Investing.com India
NextCure initiates one-for-twelve reverse stock split on Nasdaq By Investing.com - Investing.com Nigeria
NextCure Implements Reverse Stock Split on Nasdaq - TipRanks
NextCure initiates one-for-twelve reverse stock split on Nasdaq - Investing.com
NextCure Announces One-for-Twelve Reverse Stock Split - TipRanks
Finanzdaten der Nextcure Inc-Aktie (NXTC)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.97%
0.22%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):